CONTENT VALIDATION AND DISCLOSURES
Postgraduate Institute for Medicine (PIM)
assesses conflict of interest with its instructors,
planners, managers and other individuals who
are in a position to control the content of CNE
activities. All relevant conflicts of interest that are
identified are thoroughly vetted by PIM for fair
balance, scientific objectivity of studies utilized
in this activity, and patient care recommendations.
PIM is committed to providing its learners
with high-quality CNE activities and related
materials that promote improvements or quality
in healthcare and not a specific proprietary
business interest of a commercial interest.
The faculty reported the following financial
relationships or relationships to products or
devices they or their spouse/life partner have
with commercial interests related to the content
of this CNE activity:
Dr Miller — Contracted Research: Genentech
BioOncology. Ms Harkins — No financial interests or
affiliations to disclose. Dr Blum — Fees for Non-CME
Services Received Directly from Commercial Interest
or Their Agents: Abraxis Oncology.
The planners and managers reported the
following financial relationships or relationships
to products or devices they or their spouse/life partner have with commercial interests related
to the content of this CNE activity:
Richard Kaderman, PhD, Neil Love, MD, Douglas
Paley, Margaret Peng, Lilliam Sklaver Poltorack,
PharmD, Ginelle Suarez, Erin Wall and Kathryn
Ault Ziel, PhD — no real or apparent conflicts of
interest to report; Sally Bogert, RNC, WHCNP
— shareholder of Amgen Inc and Genentech
BioOncology. Research To Practice receives
education grants from Abraxis Oncology,
Amgen Inc, AstraZeneca Pharmaceuticals
LP, Bayer Pharmaceuticals Corporation/Onyx
Pharmaceuticals Inc, Genentech BioOncology/
OSI Pharmaceuticals Inc, Genomic Health Inc,
Roche Laboratories Inc and Sanofi-Aventis, who
have no influence on the content development of
our educational activities.
The following PIM clinical content reviewers,
Jan Hixon, RN, Linda Graham, RN and Trace
Hutchison, PharmD, state that they or their
spouse/life partner do not have any financial
relationships or relationships to products or
devices with any commercial interests related to
the content of this CNE activity of any amount
during the past 12 months.
This educational activity may contain discussion
of published and/or investigational uses of
agents that are not indicated by the FDA.
Postgraduate Institute for Medicine (PIM),
Research To Practice, Abraxis Oncology,
AstraZeneca Pharmaceuticals LP, Genentech
BioOncology and Genomic Health Inc do not
recommend the use of any agent outside of the
labeled indications.
The opinions expressed in the educational
activity are those of the faculty and do not necessarily
represent the views of PIM, Research
To Practice, Abraxis Oncology, AstraZeneca
Pharmaceuticals LP, Genentech BioOncology
or Genomic Health Inc. Please refer to the
official prescribing information for each
product for discussion of approved indications,
contraindications and warnings.
